Intestinal lymphangiectasia: Understanding the bigger picture
- PMID: 38983414
- PMCID: PMC11229932
- DOI: 10.12998/wjcc.v12.i18.3298
Intestinal lymphangiectasia: Understanding the bigger picture
Abstract
Intestinal lymphangiectasia (IL) is characterized by the dilation of intestinal lymphatic vessels, which can rupture and cause loss of lymph into the intestine. Due to the high content of proteins, lipoproteins, and lymphocytes in the intestinal lymph, loss of lymph might result in hypoproteinemia, hypoalbuminemia, hypogammaglobulinemia, and lymphocytopenia. In addition, there may be a depletion of minerals, lipids, and fat-soluble vitamins. IL can be primary due to inherent malfunctioning of the lymphatic system, or secondly, a result of various factors that may hinder lymphatic drainage either directly or indirectly. This condition has emerged as a subject of significant clinical interest. Given that the intestinal lymphatic system plays an important role in the body's fluid homeostasis, adaptive immunity, nutrient and drug absorption, intestinal transport, and systemic metabolism, its dysfunction may have wider implications. Although primary IL is rare, with varied clinical features, complications, treatment response, and outcomes, secondary IL is more common than previously believed. The definitive diagnosis of IL requires endoscopic demonstration of whitish villi (which frequently resemble snowflakes) and histological confirmation of dilated lacteals in the small intestinal mucosa. Treatment of IL is challenging and involves dietary modifications, managing underlying medical conditions, and using medications such as sirolimus and octreotide. Recognizing its prevalence and diverse etiology is crucial for targeted management of this challenging medical condition. This article provides a comprehensive exploration of the clinical implications associated with IL. In addition, it offers valuable insights into critical knowledge gaps in the existing diagnostic and management landscape.
Keywords: Intestinal lymphatics; Lacteals; Lymph; Lymphangiectasia; Waldman's disease.
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: The authors declare that they have no conflict of interest for this article.
Figures


Similar articles
-
Intestinal lymphangiectasia in adults.World J Gastrointest Oncol. 2011 Feb 15;3(2):19-23. doi: 10.4251/wjgo.v3.i2.19. World J Gastrointest Oncol. 2011. PMID: 21364842 Free PMC article.
-
Primary intestinal lymphangiectasia (Waldmann's disease).Orphanet J Rare Dis. 2008 Feb 22;3:5. doi: 10.1186/1750-1172-3-5. Orphanet J Rare Dis. 2008. PMID: 18294365 Free PMC article. Review.
-
Intestinal Lymphangiectasia Associated With Refractory Ascites in a Cirrhosis Patient.Cureus. 2021 Jan 7;13(1):e12567. doi: 10.7759/cureus.12567. Cureus. 2021. PMID: 33564554 Free PMC article.
-
Primary intestinal lymphangiectasia presenting as limb hemihyperplasia: a case report and literature review.BMC Gastroenterol. 2021 May 18;21(1):225. doi: 10.1186/s12876-021-01813-6. BMC Gastroenterol. 2021. PMID: 34006223 Free PMC article. Review.
-
Elderly Onset Primary Intestinal Lymphangiectasia-A Rare Case.JGH Open. 2025 Jan 22;9(1):e70102. doi: 10.1002/jgh3.70102. eCollection 2025 Jan. JGH Open. 2025. PMID: 39850090 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources